Furthermore, MIEF2 (mitochondrial elongation factor 2) increased SREBP1 and SREBP2 by activating ROS/AKT/mTOR signaling to drive the lipid synthesis in ovarian cancer cells.34 This evidence concerns the gene MTOR and ovarian cancer.